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S U M M A R Y
Objectives: The emergence of carbapenem-resistant Acinetobacter baumannii has been observed
worldwide. We describe the ﬁrst detection of A. baumannii carrying the blaNDM-1 gene in Lebanon,
isolated from Syrian patients wounded during the civil war.
Methods: Four carbapenem-resistant A. baumannii strains isolated in 2012 in the Tripoli Government
Hospital, Lebanon, from civilians wounded during the Syrian war, were analysed. Susceptibility was
determined by disk diffusion testing, and resistance to carbapenems was conﬁrmed by Etest. The
presence of blaOXA-23-like, blaOXA-24-like, blaOXA-58-like, blaOXA-143-like, and blaNDM was investigated by PCR.
Clonal relationships were studied by pulsed-ﬁeld gel electrophoresis (PFGE), multilocus sequence typing
(MLST), and blaOXA-51 sequence-based typing.
Results: All isolates harboured the blaNDM-1 gene and were negative for other tested carbapenemases.
They all belonged to the sequence type 85 and formed a single cluster by PFGE. Finally, blaOXA-51-like gene
sequencing revealed the presence of the blaOXA-94 variant in all four isolates.
Conclusion: These ﬁndings show that Syria constitutes a reservoir for NDM-1-producing bacteria. These
results also highlight the need for effective measures to stop the threatening spread of such strains.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
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Multidrug-resistant (MDR) Acinetobacter baumannii are associ-
ated with a wide spectrum of infectious diseases, ranging from
nosocomial and community-acquired infections to those acquired
in natural disasters or war.1 The main mechanism of resistance to
carbapenems in A. baumannii is the production of acquired OXA-
type carbapenemases, encoded mostly by blaOXA-23-like, blaOXA-24-
like, and blaOXA-58-like genes, which have been identiﬁed frequently
worldwide.1 In 2008, New Delhi metallo-b-lactamase 1 (NDM-1),
encoded by the blaNDM-1 gene and conferring resistance to all the
b-lactams including carbapenems, was discovered in Enterobac-
teriaceae isolates isolated in Sweden from a patient hospitalized in
India.2 Since this ﬁrst description, the enzyme has been reported* Corresponding author. Tel.: +33 2 41 35 50 13; fax: +33 2 41 35 41 64.
E-mail address: makempf@chu-angers.fr (M. Kempf).
http://dx.doi.org/10.1016/j.ijid.2014.01.004
1201-9712  2014 The Authors. Published by Elsevier Ltd on behalf of International Sothroughout the world as an emerging carbapenemase widely
detected in clinical Enterobacteriaceae, but also in A. baumannii, in
which the blaNDM-1 and blaNDM-2 genes have recently been
identiﬁed.3
Here, we report the ﬁrst detection of carbapenem-resistant
Acinetobacter baumannii carrying the blaNDM-1 gene in Lebanon,
isolated from Syrian patients wounded during the civil war.
2. Materials and methods
2.1. Isolates and antimicrobial susceptibility testing
A total of four carbapenem-resistant A. baumannii isolates were
analysed. Species identiﬁcation was conﬁrmed by real-time PCR of
the blaOXA-51 gene and rpoB gene sequencing.
4 Antimicrobial
susceptibility was determined by disk diffusion, in accordance
with the recommendations of the European Committee on
Antimicrobial Susceptibility Testing (http://www.eucast.org),ciety for Infectious Diseases. Open access under CC BY-NC-SA license.
Table 1
Epidemiological data of the four carbapenem-resistant Acinetobacter baumannii carrying the blaNDM-1 gene isolated in Lebanon from Syrian war casualties
Patient Age/gender Nationality Isolation source Hospitala Admission date
(DD/MM/YYYY)
Antibiotic susceptibility
IMI MER DOR CAZ CIP GM AM COL TG RIF DOX
1 24/M Syrian Wound, foot TGH 29/05/2012 R R R R R S S S S S S
2 24/M Syrian Wound, foot TGH 02/06/2012 R R R R R S S S S S S
3 14/F Syrian Wound, hand TGH 14/06/2012 R R R R R S S S S S S
4 1/F Syrian Wound, shoulder TGH 14/06/2012 R R R R R S S S S S S
IMI, imipenem; MER, meropenem; DOR, doripenem; CAZ, ceftazidime; CIP, ciproﬂoxacin; GM, gentamicin; AM, amikacin; COL, colistin; TG, tigecycline; RIF, rifampin; DOX,
doxycycline; R, resistant; S, susceptible.
a TGH, Tripoli Governmental Hospital, government hospital of Kobbe, Tripoli, in northern Lebanon.
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doripenem) was conﬁrmed by Etest diffusion (bioMe´rieux, Marcy
l’Etoile, France).
2.2. PCR assays and molecular typing
Real-time PCR was done to screen for the presence of blaOXA-23-
like, blaOXA-24-like, blaOXA-58-like, and blaOXA-143-like genes.
5 The
presence of blaNDM genes was investigated by standard PCR
ampliﬁcation. Sequencing of the entire carbapenem resistance
gene was performed.
Genotyping was performed by pulsed-ﬁeld gel electrophoresis
(PFGE) using ApaI enzyme and multilocus sequence typing (MLST),
in accordance with the Pasteur Institute instructions (http://
www.pasteur.fr/mlst). Moreover, the blaOXA-51-like gene was
sequenced and compared to all identiﬁed variants.
3. Results and discussion
The carbapenem-resistant A. baumannii presented here were
isolated from civilians wounded in 2012 during the Syrian war and
admitted to the government hospital of Kobbe, Tripoli, in northern
Lebanon (Table 1). The four isolates had high-level resistance to
carbapenems since the minimum inhibitory concentrations (MICs)
for imipenem, meropenem, and doripenem were >32 mg/l. The
isolates were also resistant to ﬂuoroquinolones, but remained
susceptible to aminoglycosides, doxycycline, tigecycline, rifampin,
and colistin. They all carried the blaNDM gene and were negative for
the other carbapenem resistance genes tested. Sequencing of the
blaNDM gene showed that the variant was the blaNDM-1 gene in all
four isolates.
Multidrug-resistant and blaNDM-1 gene-carrying A. baumannii
are increasingly reported worldwide. Since 2010, they have been
identiﬁed in various parts of the world, in particular in North Africa
and the Middle East,6 but to our knowledge, this is the ﬁrst report
of carbapenem-resistant A. baumannii carrying the blaNDM-1 gene in
Lebanon. However, two NDM-1-producing Klebsiella pneumoniae
imported from Iraq were detected in 2010.7 To date, no NDM-1-
producing A. baumannii has been described in Syria; however this
is a country where data on the prevalence of A. baumannii
antibiotic resistance remain limited. Recently, Hamzeh et al.
published a report in which 260 A. baumannii isolates isolated from
patients hospitalized in the area of Aleppo were studied.8 They
showed that 66% of the isolates were resistant to carbapenems, but
no further molecular epidemiological studies to explore resistance
mechanisms were performed.
Outbreaks of MDR A. baumannii infections have been reported
previously during war, as shown by Scott et al. and Kusradze et al.,
who studied the bacteria isolated in US service members injured in
Iraq.9,10 However, no isolate harbouring a blaNDM-1 gene was found
among the casualties. Although a majority of NDM-1-producing A.
baumannii are isolated in the hospital setting, it is possible that thebacterium can be isolated from various environmental locations
worldwide, even if the reservoir of such MDR isolates is not yet
well known. In the present study, the origin of the A. baumannii
infection in injured patients was difﬁcult to determine. We were
unable to obtain information on the date of injury, conditions of
care, or on the treatment administered in Syria. The infection may
have been acquired from environmental sources on the battleﬁeld,
during the patient’s stay in Syrian clinics, or during evacuation
from the operation theatre to Lebanon.
The PFGE analysis showed that the four isolates shared identical
patterns. The MLST analysis showed that all isolates belonged to
sequence type 85 (ST85), and sequencing of the blaOXA-51-like gene
identiﬁed blaOXA-94 as a unique variant. Reports of ST85-type
strains worldwide are rare. Two A. baumannii belonging to the ST85
clone and carrying the blaNDM-1 gene have recently been described
in France. Those strains were isolated from rectal swabs and
harboured the blaOXA-94 variant.
6
In conclusion, this study reports the spread of NDM-1-
producing A. baumannii in Syria, showing that this country
constitutes a reservoir for NDM-1-producing bacteria. This
information is of major importance, since because of the civil
war, many injured people are being transferred to foreign hospitals
for treatment. Among these hospitals, those in Lebanon are the ﬁrst
affected. These results highlight the importance of implementing
effective infection control measures to stop the threatening spread
of such resistant microorganisms.
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